# Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis

> **NCT00828230** · PHASE2 · TERMINATED · sponsor: **Dr. Falk Pharma GmbH** · enrollment: 17 (actual)

## Conditions studied

- Radiation Proctitis

## Interventions

- **DRUG:** budesonide
- **DRUG:** Placebo foam

## Key facts

- **NCT ID:** NCT00828230
- **Lead sponsor:** Dr. Falk Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-10
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Study was prematurely stopped due to slow recruitment after 17 of 32 anticipated patients were recruited.
- **Last updated:** 2012-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828230, "Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00828230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*